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Cytokinesis is the final step in cell division when the cell separates the cytoplasm 
by contracting a ring composed of filamentous actin (F-actin) and type II myosin.  Iqg1, 
an IQGAP family member, is an essential scaffolding protein in budding yeast (S. 
cerevisiae) required for actin recruitment to, and contraction of, the actomyosin ring.  
Actin is recruited by the calponin homology domain (CHD) in anaphase after Iqg1 is 
localized to the bud neck. Consensus sites for the cyclin-dependent kinase (CDK) Cdc28 
were identified flanking the CHD.  This led us to the hypothesis that phosphorylation of 
Iqg1 by Cdc28 negatively regulates actin ring formation prior to anaphase, and that 
dephosphorylation of Iqg1 by the phosphatase Cdc14 promotes actin ring formation.  To 
test this hypothesis the four perfect consensus CDK phosphorylation sites were mutated 
to alanine to prevent phosphorylation (iqg1-4A).  Morphological analysis of cells 
expressing mutant protein indicated cytokinetic failure at more than double the rate of 
controls.  This data indicates that phosphorylation of Iqg1 by CDK is important for 
cytokinesis.  Using immunofluorescence we observed that cells expressing iqg1-4A form 
both Iqg1 and actin rings prior to anaphase.  These data support the hypothesis that the 
dephosphorylation of the 4 CDK sites in Iqg1 promotes actomyosin ring formation.  We 
also provide evidence that Cdc14 is the key regulator of actin ring formation.  
Overexpression of Cdc14 resulted in formation of the actin ring prior to anaphase similar 
to iqg1-4A.  Inhibition of Cdc14 prevented actin ring formation even in the presence of an 
inhibitor of Cdc28 that bypasses the mitotic arrest typically seen in CDC14 mutants.  The 
iqg1-4A mutant can rescue the ability of cdc14-1 cells to form actin rings.  These results 
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1.1. CYTOKINESIS  
  
Cytokinesis is the final step in cell division that divides the cytoplasm between 
two daughter cells.  This process must be closely controlled both spatially and temporally 
and involves the coordinated activity of more than 130 cytokinesis proteins (Schroeder 
1990, Satterwhite and Pollard 1992, Pollard 2010).  Precise temporal control is necessary 
to coordinate cytokinesis and mitosis so that proper chromosome segregation can be 
completed.  Cytokinetic failure results in tetraploid cells, which can be either beneficial 
or detrimental.  Regulated inhibition of cytokinesis can sometimes be necessary to create 
specialized cell types.  The megakaryocytes, which produce platelets by shedding their 
cytoplasmic processes, can have up to 64N nuclear content, and are produced by mitosis 
without cytokinesis (Tomer, Harker et al. 1988, Gieger, Radhakrishnan et al. 2011).  
However, tetraploidy can also be an intermediate state leading to chromosomal 
instability, aneuploidy, and tumorigenesis (Ganem, Storchova et al. 2007, Storchova and 
Kuffer 2008). 
The cytokinetic process is highly conserved between animal and fungal cells.  The 
process has distinct events including division site specification, targeted membrane 
deposition, and actomyosin ring assembly and contraction, and all of these events are in 
some way controlled by the cell cycle regulators (Wloka and Bi 2012).  As shown in 
Figure 1.1, while the overall process is very similar between the two kingdoms, there are 
some key differences even between different fungi. 
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Yeast and animal cells undergo cytokinesis using conserved proteins, structures, 
and processes (reviewed by (Pollard 2010)).  In both animal and fungal cells the 
actomyosin ring is a transient structure and is precisely positioned to bisect the elongating 
anaphase spindle ensuring proper chromosome segregation (Pollard 2010).  Unlike 
animal cells, yeast also have a cell wall, and must coordinate cytokinesis with new cell 




Figure 1.1 Drawing of contractile ring assembly and constriction in three model 
organisms.  





1.1.1. Division Site.  In budding yeast Saccharomyces cerevisiae, the site of  
division is determined at the beginning of the cell cycle, when a daughter bud forms in 
G1.  The bud is connected to the mother cell by a narrow region called the bud neck, 
which is the future site of cell division.  Most other cell types determine the site of cell 
division later in the cell cycle. Fission yeast determine the site of division just before 
mitosis based on the location of the nucleus, while animals cell use the position of the 
spindle during mitosis (Casamayor and Snyder 2002, Oliferenko, Chew et al. 2009).  
However, once the site of cell division is selected all eukaryotic cells use an actomyosin 
based contractile ring to accomplish cytokinesis. 
1.1.2. Cell Wall Deposition.  Because yeasts are surrounded by a cell wall as  
well as the cell membrane, cytokinesis in yeasts is coupled to addition of new cell wall 
material in a process known as septum formation.  Septum formation is the functional 
equivalent of localized extracellular matrix remodeling in animal cells, and in budding 
yeast it begins when chitin synthase II, Chs2, produces the chitinous primary septum, PS.  
Deletion of CHS2 causes asymmetric actomyosin ring contraction, indicating that it is 
necessary for actomyosin ring stability during contraction (VerPlank and Li 2005, Wloka 
and Bi 2012).  Deletion of MYO1 results in cytokinesis failure and a misoriented PS, 
(Fang, Luo et al. 2010) suggesting that the actomyosin ring may guide PS formation 
(Fang, Luo et al. 2010). 
During mitosis Chs2 is synthesized and retained in the ER through 
phosphorylation by the cyclin dependent kinase (CDK) Cdc28.  At the onset of 
cytokinesis Chs2 is dephosphorylated by Cdc14, a phosphatase that is part of the Mitotic 
Exit Network (MEN), which releases Chs2 from the ER (Chin, Bennett et al. 2012).  
Another level of cell cycle control occurs via the phosphorylation of Chs2 by Dbf2, 
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which is also part of the MEN.  Phosphorylation by Dbf2 occurs approximately halfway 
through actomyosin ring constriction and causes Chs2 to dissociate from the bud neck 
(Devrekanli, Foltman et al. 2012, Oh, Chang et al. 2012).  This is necessary because 
persistent Chs2 causes asymmetric distribution of the actomyosin ring (Oh, Chang et al. 
2012).  Clearly the Mitotic Exit network plays an extensive role regulating Chs2 
dynamics, and accordingly many MEN mutants are defective for PS formation 
(Meitinger, Petrova et al. 2010).  After the PS is fully formed two secondary septa, SS, 
which are similar in composition to the general cell wall, are constructed on both sides of 
the PS.  Breakdown of the primary septum leads to cell separation. 
1.1.3. Actomyosin Ring.  In animal and yeast cells, cytokinesis is thought to be  
achieved by contracting a ring composed of filamentous actin (F-actin) and non-muscle 
type II myosin (Satterwhite, Lohka et al. 1992, Fishkind and Wang 1995).  In budding 
yeast, the single type II myosin is named Myo1.  Myo1, like other type II myosins, has 
two heads that function as an ATP driven motor that pulls along actin cables.  It has long 
been assumed that Myo1 activity on actin cables in the actomyosin ring is what provided 
the contractile force necessary for ring contraction.  Based on actomyosin force 
production in striated muscles a sliding filament mechanism (Figure 1.2) was theorized 
(Schroeder 1975).  However, deletion of the Myo1 motor domain only slows the rate of 
actomyosin ring contraction, indicating that the motor activity is not strictly required for 
cytokinesis (Lord, Laves et al. 2005, Fang, Luo et al. 2010).  A new model in budding 
yeast suggests that actin depolymerization is the major force producing mechanism, with 
Myo1 motor activity playing a minor role (Abe, Obinata et al. 1996, Mendes Pinto, 
Rubinstein et al. 2012).  In mammalian fibroblast cells, NIH 3T3, a knockdown of the 
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actin depolymerizer Cofilin-1 results in defective cytokinesis (Hotulainen, Paunola et al. 
2005).  In these cells the alignment of myosin II and F-actin occurred similarly to wild-
type cells, however the contraction of the actomyosin ring was defective.  Furthermore 
the overall cytokinesis process went from taking approximately 30 minutes to taking 90 
minutes (Hotulainen, Paunola et al. 2005).  So while the actomyosin ring may seem 
similar to the structure of the sarcomere in muscle cells, it differs in both composition and 




Figure 1.2 Theoretical model of actin and myosin interactions sliding filament model 





1.1.4. Septins.  In budding yeast the actomyosin ring is assembled throughout the  
cell cycle and, like septum formation, is dependent on septin proteins.  Septins are GTP 
binding proteins that form scaffolding that provide structural support and 
compartmentalize these two processes.  The septin proteins form an hourglass structure 
early in the cell cycle at the future bud site (Figure 1.3).  At the onset of cytokinesis the 
MEN causes the hourglass structure to split into two separate rings before cell division 
allowing actomyosin ring constriction (Lippincott, Shannon et al. 2001).  However, when 
MEN mutants are forced to exit mitosis using the CDK inhibitor Sic1 the septin hourglass 
splits but the actomyosin ring cannot constrict.  This suggests that actomyosin ring 
constriction does not solely depend on septin hourglass splitting (Meitinger, Petrova et al. 
2010).  Thus the septins are under cell cycle control via the MEN but they don’t control 
actomyosin ring contraction.   
 
 




1.1.5. Actomyosin Ring Assembly.  The first component of the actomyosin ring  
to localize to the bud neck is the type II myosin heavy chain, Myo1, which forms a ring at 
the bud neck in G1 and is targeted there by two phases (Figure 1.4).  The first phase is 
mediated by interactions between Myo1 and the septin binding protein Bni5 from late G1 
to the onset of telophase (Lee, Song et al. 2002).  In septin mutants Myo1 fails to 
localize, thus, Myo1 localization is dependent on the septin proteins that form the 
hourglass structure (Bi, Maddox et al. 1998, Lippincott and Li 1998).  The second phase 
is mediated via interaction between Myo1’s essential light chain, Mlc1, and Iqg1 during 
the time from anaphase to the end of cytokinesis (Fang, Luo et al. 2010)  
The formins Bnr1 and Bni1 and the IQGAP family member Iqg1/Cyk1 are 
required for assembly and contraction of the actomyosin ring.  Formins are actin binding 
proteins that contain an FH2 domain that nucleates actin filaments.  The formins facilitate 
nucleation of actin allowing for filament assembly into linear arrays such as actin cables 
or the cytokinetic actin ring (Faix and Grosse 2006).  Bni1 nucleates actin cables in the 
bud while Bnr1 polymerizes actin cables at the bud neck (Pruyne, Gao et al. 2004).   
Localization of F-actin in the cytokinetic ring occurs after anaphase (Lippincott and Li 






Figure 1.4 Stepwise assembly of the budding yeast actomyosin ring.   
At the G1/S transition, septins and then Myo1p and Mlc1p localize to the bud neck.  
During late anaphase, Iqg1p/Cyk1p (green arrows) is recruited to the bud neck by Mlc1p 
and then recruits F-actin (Tolliday, Bouquin et al. 2001) 
 
1.2. IQG1 
IQGAP family members are essential for actin based processes such as 
phagocytosis, cell adhesion, migration and cytokinesis (Malarkannan, Awasthi et al. 
2012, Shannon 2012).  Mammalian cells contain three IQGAP proteins, IQGAP1, 
IQGAP2, and IQGAP3.  IQGAP1 is currently the best studied family member and is 
most closely related to budding yeast IQG1 (Figure 1.5).  Human IQGAP proteins are in 
involved in cancer cell metastasis and altered expression has been implicated in 
tumorigenesis (Johnson, Sharma et al. 2009).  IQGAP1 is over expressed is a range of 
different tumors and shows distinct membrane localization that may contribute to cancer 
cells weakening of cell:cell adhesion and stimulation of cell motility pathways (Johnson, 
Sharma et al. 2009).  IQGAP proteins in yeasts play a major role in cytokinesis, 
localizing to the site of cytokinesis and recruiting actin to the cytokinetic ring.  
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  IQGAP family members share multiple functional domains and combine with 
many binding partners giving these proteins their wide variety of functions.  Iqg1 (Figure 
1.5) is the only  IQGAP family member in budding yeast and is a 173 kD scaffolding 
protein (Epp and Chant 1997).  Iqg1 contains the following domains: an N-terminal 
Calponin Homology Domain (CHD), 11 IQ repeats, a GTPase Related Domain (GRD), 
and a Ras-GAP C-terminus (RGCT). (Shannon and Li 1999, Boyne, Yosuf et al. 2000, 
Shannon and Li 2000).   
Iqg1 is required for the recruitment of actin to the actomyosin ring.  In the 
absence of Iqg1 cells fail to form an actin ring (Epp and Chant 1997, Lippincott and Li 
1998, Shannon and Li 1999).  Specifically it is the CHD portion of Iqg1 that is required 
for F-actin recruitment.  In cells containing a deletion of just the CHD region of Iqg1, 
Iqg1 still localized to the bud neck but none of these cells contain actin rings (Shannon 
and Li 1999). 
Iqg1p is recruited to the bud neck by the Myosin Regulatory Light Chain, Mlc1, 
via interactions with the IQ domains.  However, Mlc1 localizes to the bud neck earlier in 
the cell cycle than Iqg1.  Cells with a deletion of the IQ domain fail to localize Iqg1 to the 
bud neck and also fail to form an actin ring (Shannon and Li 1999).  Point mutations in 
Mlc1 that affect its interactions with Iqg1 also display defects in cytokinesis (Luo, Vallen 
et al. 2004).  Disruption of the MLC1 gene results in cytokinesis defects, presumably 
because cells fail to localize Iqg1, and therefore actin, and is lethal (Epp and Chant 1997, 
Bi, Maddox et al. 1998, Lippincott and Li 1998, Shannon and Li 1999).  Mlc1 uses the 
existing structure of the Myo1 ring as a template to form a ring during anaphase (Boyne, 
Yosuf et al. 2000, Shannon and Li 2000).  Iqg1 has also been reported to stabilize the 
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Myo1 ring during late mitosis via interactions between Iqg1, Mlc1, and Myo1 (Shannon 
and Li 1999, Fang, Luo et al. 2010). 
The C-terminus of Iqg1, containing both the GRD and RGCt domains, interacts 
with the GTPase Tem1, and is required for contraction of the actomyosin ring (Shannon 
and Li 1999).  Tem1 is the starting point of the MEN and is active when bound to GTP.  
Once Tem1 is active it leads to the full release of Cdc14 from the nucleolus and exit from 
mitosis.  Iqg1 with a deletion of the GRD can still localize to the bud neck but contraction 
of the actomyosin ring does not occur (Shannon and Li 1999). 
 
 
Figure 1.5 IQGAP family members.  
 A) Human IQGAP family member IQGAP1.  B) Budding yeast IQGAP Iqg1.  
Abbreviations: Calponin Homology Domain (CHD), 11 IQ repeats, a GTPase Related 
Domain (GRD), and a Ras-GAP C-terminus (RGCT).  Solid black lines are known 





1.3. CYCLIN DEPENDENT KINASE  
Cyclin-dependent kinases (CDK) are essential enzymes that drive the cell through 
the cell cycle in eukaryotes.  The cyclin dependent kinase Cdc28/Cdk1 is the only CDK 
in budding yeast and is responsible for regulating cycle-dependent processes such as 
transcription, DNA replication and repair, chromosome segregation during mitosis, and 
cytokinesis (Fisher, Krasinska et al. 2012, Koltovaya 2013).  Cdc28 was the first CDK 
discovered and is the currently the best understood cyclin dependent kinase.  CDKs are 
conserved from yeast to mammalian cells, so much so that the human gene, Cdk1, can be 
used to rescue deletion of yeast CDK (Lee and Nurse 1987). 
Cdc28 inhibits exit from mitosis by phosphorylating targets involved in mitotic 
exit and cell separation. The phosphorylation by Cdc28 can lower protein activity levels 
or prevent protein localization.  Cdh1, which is part of the anaphase promoting complex 
(APC) which degrades mitotic cyclins, is inactive while phosphorylated by Cdc28 during 
mitosis.  It is later activated following dephosphorylation by the MEN component Cdc14 
(Visintin, Craig et al. 1998, Crasta, Lim et al. 2008).  Prior to metaphase Sic1, which 
inhibits the kinase activity of Cdc28, is phosphorylated by Cdc28 marking it for 
ubiquitin-mediated proteolysis.  This targeting makes Sic1 highly unstable preventing its 
inhibitory activities on Cdc28 (Verma, Feldman et al. 1997).  Both of these actions by 
Cdc28 prevent its own inactivation prior to anaphase.   
Cdc28 directly phosphorylates Chs2 preventing its transport to the bud neck until 
late anaphase resulting in defective septation (Teh, Chai et al. 2009).  Hof1 has been 
shown to be directly phosphorylated by Cdc28-Clb2 priming it for phosphorylation by 
Cdc5 (Yoshida and Toh-e 2001, Asano, Park et al. 2005, Meitinger, Boehm et al. 2011).  
Iqg1 a protein required for cytokinesis has also recently been shown to be phosphorylated 
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by Cdc28 (Zhang, Morgan et al. 2014). Other targets of Cdc28 that are involved in cell 
cycle regulation and cytokinesis have been identified by proteomic screening which 
include: Lte1, Mob1, Net1, and Swi5 (Ubersax, Woodbury et al. 2003, Costanzo, 
Baryshnikova et al. 2010).  Cdc28’s effects on these proteins are not well understood. 
Cdc28 is inactivated during anaphase via two partially redundant methods, 
inhibition of its kinase activity by Sic1, and degradation of the mitotic cyclins by the 
APCCdh1 complex (Bloom, Cristea et al. 2011, Koltovaya 2013).  Sic1, a protein that 
inhibits the kinase activity of Cdc28, is inactive until it is dephosphorylated by the MEN 
component Cdc14.  Once active it binds the Cdc28-Clb complex inhibiting it.  
Overexpression of Sic1 bypasses mitotic arrest and rescues most mutants of the MEN 
except for mutants of the Cdc14 phosphatase (Fitzpatrick, Toyn et al. 1998, Jaspersen, 
Charles et al. 1998).  
The second method of inactivation occurs via the destruction of mitotic cyclins.  
The MEN protein Cdc14 dephosphorylates Cdh1, a substrate adaptor protein of the APC, 
activating the APCCdh1 complex.  Cdh1 regulates the substrate specificity of the ubiquitin 
E3-ligase of the APC.  Cdh1 recruits the mitotic cyclins to the complex which attaches 
chains of ubiquitin marking the protein for degradation by the proteasome, thus 
destroying the mitotic cyclins required for Cdc28’s kinase activity during mitosis.   
When the activity of Cdc28 drops, MEN proteins Cdc15, Dbf2-Mob1, Dbf20-
Mob1, and Cdc14 all accumulate to the bud neck by an unknown mechanism (Jaspersen, 




1.4. MITOTIC EXIT NETWORK 
The Mitotic Exit Network (MEN) regulates mitotic exit, cytokinesis, and 
septation.  The MEN is a signaling cascade that leads to mitotic exit via the full release 
and activity of Cdc14, a phosphatase that leads to the degradation of mitotic cyclins and 
dephosphorylation of many targets of the budding yeast CDK, Cdc28 (Figure 1.6) 
(Meitinger, Palani et al. 2012).  The MEN starts with the activation of the GTPase Tem1.  
Tem1 localization to spindle pole bodies is essential for MEN activation (Valerio-
Santiago and Monje-Casas 2011).  Tem1 is active in its GTP bound state, and Tem1 
activity is blocked by the Bfa1-Bub2 complex by promoting GTP hydrolysis (Geymonat, 
Spanos et al. 2002, Pereira, Manson et al. 2002).  The putative guanine nucleotide 
exchange factor (GEF), Lte1, presumably promotes Tem1 activation, however the 
molecular mechanism is unknown (Geymonat, Spanos et al. 2002, Konig, Maekawa et al. 
2010).  The spindle position checkpoint inactivates Tem1 when the mitotic spindle is 
incorrectly positioned (Caydasi, Ibrahim et al. 2010).  Tem1 is inhibited until the mitotic 
spindle is positioned perpendicularly to the site of cell division.  Once Tem1 is bound by 
GTP it activates the Cdc15 kinase, which increases the activity of the Mob1-Dbf2 kinase 
complex.  Activity of the Polo kinase Cdc5 is also required for Cdc15 association with 
spindle pole bodies (Rock and Amon 2011, Valerio-Santiago and Monje-Casas 2011).   
The Mob1-Dbf2 complex promotes the full and sustained release of Cdc14 from the 
nucleolus.  The MEN components Cdc14 and Dbf2 also play a role in septum regulation.  
Cdc14 dephosphorylates Chs2 releasing it from the ER during anaphase, while Dbf2 
phosphorylates Chs2 approximately halfway through actomyosin ring contraction causing 
its dissociation from the bud neck (Chin, Bennett et al. 2012).  Mitotic CDK must be 
inactivated in order for actomyosin ring assembly and contraction to occur (Meitinger, 
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Palani et al. 2012).  After CDK activity levels drop due to degradation of mitotic cyclins, 




Figure 1.6 FEAR and Mitotic Exit Network 
 
1.5. CDC14 
Cdc14 is a serine/threonine phosphatase required for inactivation of mitotic 
cyclins and is essential for exit from mitosis.  Early in the cell cycle, Cdc14 is bound to 
Net1 sequestering it in the nucleolus (Figure 1.6) (Shou, Seol et al. 1999, Traverso, 
Baskerville et al. 2001, Bloom, Cristea et al. 2011).  Two partially redundant mechanisms 
then release it from the nucleolus, the Cdc14 early anaphase release network, FEAR, and 
the mitotic exit network, MEN (Queralt and Uhlmann 2008, Uhlmann, Bouchoux et al. 
2011). 
Shown in Figure 1.7 below, the FEAR network promotes Cdc28-Clb2 dependent 
phosphorylation of Net1, which transiently releases Cdc14.  This small amount of Cdc14 
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dephosphorylates Swi5, Sic1 and the APC-Cdh1 complex (activating them), all of which 
were previously phosphorylated by Cdc28-Clb2 (Visintin, Craig et al. 1998, Bloom, 
Cristea et al. 2011, Koltovaya 2013).  Swi5 promotes transcription of Sic1, Sic1 inhibits 
the kinase activity of Cdc28-Clb2 and in mitotic cells promotes actomyosin ring 
assembly and partial contraction (Sanchez-Diaz, Nkosi et al. 2012).  Sic1 is initially 
inhibited by phosphorylation by Cdc28-Clb2, until Cdc14 dephosphorylates it, which 
then allows it to inhibit Cdc28 kinase activity.   
Meanwhile, the partially active Cdc14 dephosphorylates the MEN component 
Cdc15 assisting in activation of the MEN for sustained Cdc14 release and activity 
(Jaspersen, Huneycutt et al. 2004).  This dephosphorylation, the activity Tem1, and Cdc5 
all work to activate Cdc15 (Rock and Amon 2011), which then phosphorylates the Dbf2-
Mob2 complex.  Dbf2-Mob2 leads to the full and sustained release of Cdc14 (Jaspersen 
and Morgan 2000, Lew and Burke 2003, Sullivan and Uhlmann 2003).  Dbf2-Mob2 fully 
releases Cdc14 from the nucleolus and sustains this release by direct phosphorylation 
Cdc14 on serine and threonine residues adjacent to its nuclear localization signal (Mohl, 
Huddleston et al. 2009).   
Cdc14 promotes exit from mitosis by dephosphorylating many Cdc28 targets.  By 
dephosphorylating Cdh1 it activates the anaphase promoting complex, APC, allowing the 
APCCdh1 complex to degrade the mitotic cyclin Clb2, part of the Cdc28-Clb2 complex 
(Bloom, Cristea et al. 2011).  Cdc14’s activity on Sic1 allows for the inhibition of 
Cdc28’s kinase domain.  Cdc14 increases the activity of Swi5 and Sic1, further inhibiting 
Cdc28 kinase activity, and fully activating the APCCdh1 complex which degrades the 
mitotic cyclin Clb2, fully shutting down the CDK.  Temperature sensitive alleles of 
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Cdc14 arrest in anaphase/telophase with elongated spindels at the non-permissive 
temperature. 
In addition to promoting mitotic exit, Cdc14 regulates cytokinesis and septation.  
Cdc14 is required for the localization of Bni1, one of the essential formins required for 
cytokinesis, to the bud neck (McCusker, Denison et al. 2007). Cdc14 dephosphorylates 
Bni1 and Bnr1 in vitro and in vivo (Bloom, Cristea et al. 2011).  However, a role for 
Cdc14 in regulating actin ring formation has not previously been shown.  Cdc14 likely 
plays a role in primary septum formation.  It is reported that Cdc14 can dephosphorylate 
Chs2 in vitro (Chin, Bennett et al. 2012), possibly regulating Chs2 localization to the bud 
neck, since Chs2 is locked in the ER by Cdc28’s phosphorylation.  Overall Cdc28 works 
to promote mitosis while inhibiting cytokinesis, and Cdc14 works to promote exit from 
mitosis and cytokinesis by promoting the destruction of mitotic cyclins and inhibition of 









Figure 1.7 Inhibition of CDK and Degradation of Mitotic Cyclins. 
Early in mitosis, phosphorylation by Cdk1-Clb leads to downregulation of the Cdh1-
activated form of the anaphase-promoting complex (APC), the transcription factor Swi5, 
and the cyclin-dependent kinase (CDK) inhibitor Sic1. As cells enter anaphase, Cdk1 
phosphorylates Net1, triggering an initial, partial release of Cdc14 by the Cdc14 early 
anaphase release (FEAR) pathway (which also requires APC function). Concomitantly, 
the Cdc20-bound form of the APC (which is positively regulated by CDK activity) 
ubiquitylates mitotic cyclins to target them for degradation. Later in anaphase, the 
remaining Cdc14 is released due to activation of the mitotic exit network (MEN) 
pathway, allowing for more extensive dephosphorylation of mitotic phosphoproteins. 
Unphosphorylated Swi5 can trigger transcription and accumulation of Sic1, which is now 
able to evade phosphorylation-directed ubiquitinylation and degradation, leading to 
further Cdk1 inhibition. Activation of APC-Cdh1 leads to further destruction of mitotic 
cyclins as cells complete exit from mitosis. It is through this system of feedback loops 
that irreversibility of mitotic exit is ensured. 














In the yeast Candida albicans the Igq1 homolog is phosphorylated in vitro by the 
cyclin dependent kinase Cdk1.  CDKs drive and coordinate the cell cycle, and mutation 
of 15 of the 19 Cdk1 consensus sites in Iqg1 flanking the CHD resulted in premature 
assembly and delayed disassembly of the actomyosin ring, and cytokinesis defects (Li, 
Wang et al. 2008).  Analysis of the amino acid sequence of budding yeast Iqg1 showed 
that four perfect consensus sites for the cyclin-dependent kinase Cdc28 flank the CHD 
(consensus sequence (S/TPxR/K, x is any amino acid (aa) (Li, Wang et al. 2008)) (Red 
numbers around CHD in Figure 1.5).  We hypothesized that phosphorylation of these 
sites prevents actin ring formation, and that dephosphorylation of these CDK sites by 
Cdc14 promotes actin ring formation.  To test this hypothesis we constructed two 
plasmids containing mutations of all four perfect CDK consensus sites to determine their 
effects on cytokinesis and actin ring formation.  The first mutant allele is IQG1 with all 
four perfect sites mutated to alanine to prevent phosphorylation (referred to as iqg1-4A), 
and the second IQG1 with all sites mutated to glutamic acid to mimic phosphorylation 
(iqg1-4E).  Furthermore, we looked to see if there was a genetic interaction between 
Cdc14 activity and the timing of actin ring formation. 
In this study we present evidence that dephosphorylation of Iqg1 by the 
phosphatase Cdc14 temporally controls actomyosin ring formation.  Our results provide 





3. MATERIALS AND METHODS 
 
3.1. STRAINS AND MEDIA 
All S. cerevisiae strains were derived from either the S288c or W303 background 
and are listed in Table 1.  Cultures were grown at 30°C in YEP+2% D-glucose (YPD) or 
YEP+2% galactose and raffinose (YPGR), except where noted. 
 
 
Table 3.1 Yeast Strains used in this study 
Strain Genotype Background Source 
KSY 10 
RLY253 




MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 




KSY 185 MATα ade2-1 can1-100 his3-11, 15 leu2-3, 
112 trp1-1 ura3-1 IQG1-3HA::His3MX6 
W303 (Pringle 
lab) 
KSY 286 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc 
  
KSY 378  MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc, URA3 
iqg1-4A-myc, HIS3 (pDM9) 
S288c This work 
KSY 396 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc, URA3 
iqg1-4E-myc, HIS3 (pDM15)  
S288c This work 
KSY 379 
RLY 226 
MATa/α ura3-52 his3 lue2-3, trp, 
ΔIQG1:LEU2 /IQG1 s288c pIQG1-myc 
S288c This work 
KSY 418 MATα H+L +spore from 
KSY379xKSY378ΔIQG1:LEU2 iqg1-4A:HIS3 
S288c This work 
KSY 419 MATa H+L +spore from 
KSY379xKSY378ΔIQG1:LEU2 iqg1-4A:HIS3 
S288c This work 
KSY 470 MATa  H+L +spore from KSY379xpTL12 
ΔIQG1:LEU2  IQG1-myc:HIS3 
S288c This work 
KSY 472 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc, ura3 
(pRL170) iqg1-4A-myc, HIS3 (pDM9) 
S288c This work 
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 Table 3.1 Yeast Strains used in this study conti   
KSY 473 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc, ura3 
(pRL170) iqg1-4E-myc, HIS3 (pDM15) 
S288c This work 
KSY 478 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc, ura3 
(pRL170) iqg1-4E-myc, HIS3 (pDM15), 
IQGCH-GFP:URA3 
S288c This work 
KSY 480 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc, iqg1-
4A-myc, (pDM9), HIS3 IQGCH-GFP:URA3 
S288c This work 
KSY 
481/482 
MATa cdc14-1 ura3 leu2 SIC1 2μ:LEU2 W303 This work 
KSY 483 MATa ade2-1 ura3-1 his3-11, 15 trp1-1 leu2-3, 
112 can1-100 GAL-SIC1-ΔNT-myc:URA3 
S288c This work 
KSY 488  MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc:URA3 
iqg1-4E-myc, HIS3 (pDM15), HIS3 MYO1-
GFP:TRP 
S288c This work 
KSY 494 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc, URA3 
iqg1-4E-myc, HIS3 (pDM15), HIS MYO1-
GFP:TRP (pKT36) TUB1-Mcherry:URA 
(pAK011) 
S288c This work 
KSY 496 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc, URA3 
iqg1-4A-myc, HIS3 (pDM9) TUB1-Mcherry 
:HIS:URA (pAK011) 
S288c This work 
KSY 504 MATa cdc14-1 ura3 leu2 GAL-SIC1ΔNT:URA 
(pFM160) 
W303 This work 
KSY 507 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc cdc28-
4 
S288c This work 
KSY 508 MATa ura3-52 his3-Δ200 leu2-3, 112 lys2-801 
Δbar1 ΔIQG1:LEU2 pGAL1-IQG1-myc, URA3 
iqg1-4A-myc, HIS3 (pDM9) TUB1-
Mcherry:URA (pAK011) MYO1-GFP:TRP 
(pKT36) 
S288c This work 
KSY 509 MATa ura3 leu2 his3 trp1 ade2 Δbar1 GAL1-
CDC14 (pKL1341) 
W303 This work 
KSY 510 MAT? cdc14-1 ura3 leu2 ΔIQG1:LEU2 
(pRL170) iqg1-4A, HIS3 (pDM9) GAL1-SIC1-
ΔNT-myc:URA3 (pFM160)  





3.2. PLASMID CONSTRUCTION AND MUTAGENESIS  
 Plasmids are listed in Table 2.  To make the IQG1 phospho-mutant plasmids the 
Stratagene QuikChange II XL Multi Site-Directed Mutagenesis Kit was used to mutate 
pTL12, which contains full length IQG1 under its endogenous promoter with a myc tag 
on the C-terminus (Lippincott and Li 1998).  The kit was used per manufacturer’s 
instruction with a few modifications.  PCR primer concentration was sensitive and 
needed to be 200ng with template DNA concentration at 30ng.  The Pfu was added 5 min 
in to the following program: 95°C for 6 minutes, 1 cycle, 98°C for 1 minute, 55°C for 1 
minutes, 65°C for 20 minutes, 18 cycles, 72°C for 7 minutes, 1 cycle.   
Miniprep plasmid isolation on the Site-Directed Mutagenesis transformation 
colonies was done according to the Wizard Plus SV Minipreps DNA Purification System 
protocol and resulting purified DNA was sequenced by Missouri S&T cDNA Resource 
Center for verification of mutations.  The 4 consensus CDK sites are located at S7, T299, 
S345, and S404.  All four sites were changed either to alanine or to glutamic acid, 
creating 2 final plasmids, igq1-4A (pDM9) with all sites mutated to alanine and Iqg1-4E 









Table 3.2 Plasmids used in this study 
Name Genotype  Source 
pKT36 Myo1-GFP: TRP1 integrate with AgeI (Shannon and Li 1999). 
pTL12 IQG1-myc CEN plasmid HIS3 (Lippincott and Li 1998) 
pDM9 iqg1-4A-myc CEN plasmid HIS3 This work 
pDM15 iqg1-4E-myc CEN plasmid HIS3 This work 
pFM160 GAL1-SIC1-ΔNTmyc:URA3 integrate with 
EcoRV 
(Chin, Bennett et al. 2012) 




3.3. YEAST TRANSFORMATION 
Yeast transformations were performed by modified lithium acetate method (Gietz, 
St Jean et al. 1992) After 30 minutes incubation at 30°C, 50 μl of DMSO was added and 
mixed.  Cells were plated on appropriate media and incubated at 30°C for two to three 
days. 
  
3.4. ANALYSIS OF CELL MORPHOLOGY 
Cells expressing wild-type Iqg1 under control of the GAL1 promoter were 
cultured overnight in 5 ml YPGR at 30°C. The cells were then diluted (1ml into 5ml) into 
respective media (YPD and YPGR) and were allowed to continuing growing at 30°C for 
5-7 hours.  Both strains KSY 378 and 396 have wild type IQG1 under the GAL1 
inducible promoter allowing wild type IQG1 to be shut off in presence of glucose. Cell 
morphology was then observed using an Olympus CH2 with objective EA40 NA0.65.  
For each strain and treatment 200 cells were counted and scored as chains if they 
contained 3 or more connected cell bodies.  Zymolyase treatment was performed as 




3.5. FLUORESCENCE STAINING OF Iqg1 MUTANT CELLS 
Strains KSY 378 and KSY 396 were grown overnight in 5ml YPGR, diluted into 
50ml, and grown for 3 hours at 30 °C.  α mating factor (50l) was added and cells 
incubated for additional 3 hours to arrest cells in G1.  The cells were then pelleted and 
washed 3 times with sterile water to remove α factor.  They were then resuspended in 
35ml YPD (experimental) and YPGR (control).  Time points were taken at 20, 40, 60, 80, 
and 100 minutes after resuspension into YPD or YPGR.  Cells were fixed by addition of 
formaldehyde to 5% and rotation for 1 hour at room temperature.  Cells were then 
washed 2 times with sorbitol buffer to remove formaldehyde and stored at 4°C for up to a 
week. 
Cells were permeabilized by zymolyase treatment and then affixed to a 10 well 
microscope slide using poly-lysine.  15μl of poly-lysine was added to each well and 
allowed to air dry.  15μl of cell suspension was added and incubated for 5 minutes.  Cells 
were pipetted off and slide was allowed to air dry before being washed 3 times with 
1μg/ml PBS/BSA (Lippincott and Li, 1998b).   
Cells were stained using primary antibody mouse anti-myc 9E10 (Covance) and 
FITC-conjugated secondary antibody (Jackson ImmunoResearch Laboratories, West 
Grove, PA) as described (Lippincott and Li 1998).  Actin staining using A568 phalloidin 
(Invitrogen) was also performed as described (Lippincott and Li 1998).  Mounting 
solution containing 1μg/ml DAPI was added and coverslip was sealed to slide. 
Images were captured using an Olympus IX51 inverted microscope at 1,000X 
total magnification using a UPLSAPO 100X NA 1.4 objective.  DA/FI/Tx-3X3M-a 
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triple-band Sedat Filter set was used (Brightline).  Images were captured with a 
Hamamatsu ORCA285 CCD camera.  A prior motorized Z drive was used to capture 
image stacks of 20 Z-planes in 0.2μm steps.  Shutters, filters, and camera were controlled 
using SlideBook software (Intelligent Imaging Innovations, Denver, CO). 
 
3.6. ACTIN STAINING OF GAL1-CDC14 CELLS 
Strain KSY 509 was grown overnight in 5ml YPD at 30 °C, after resuspension 
into YPD or YPGR  nocodazole (5μg/ml) was added and cells incubated for additional 
2.5 hours to arrest cells in mitosis.  Cells were fixed by addition of formaldehyde to 5% 
and rotated for 1 hour at room temperature.  Cells were then washed 2 times with sorbitol 
buffer to remove formaldehyde and stored at 4°C for up to a week. 
Cells were permeabilized by zymolyase treatment and then affixed to a 10 well 
microscope slide using poly-lysine.  15μl of poly-lysine was added to each well and 
allowed to air dry.  15μl of cell suspension was added and incubated for 5 minutes.  Cells 
were pipetted off and slide was allowed to air dry before being washed 3 times with 
1μg/ml PBS/BSA (Lippincott and Li, 1998b).   
Actin staining using A568 phalloidin (Invitrogen) was performed as described 
(Lippincott and Li 1998).  Mounting solution containing 1μg/ml DAPI was added and 
coverslip was sealed to slide. 
 
3.7. ACTIN STAINING OF cdc14-1+SIC1 2μ CELLS 
Strain KSY 482 with a temperature sensitive cdc14-1 allele and SIC1 expressed at 
high level using a 2plasmid was used to selectively inhibit Cdc14p activity.  Cells were 
grown overnight in 5ml YPD at room temp (RT), after resuspension into fresh YPD, 
26 
 
nocodazole (5μg/ml) was added and cells incubated for additional 2 hours to arrest cells 
in mitosis.  Cells were then placed at RT (control) and 37°C (experimental) for 90 
minutes.  A sample was taken before nocodazole was removed. After 2x dH20 washes a 
10 minute and 20 minute time point was taken.  Cells were fixed by addition of 
formaldehyde to 5% and rotation for 1 hour at room temperature.  Cells were then 
washed 2 times with sorbitol buffer to remove formaldehyde and stored at 4°C for up to a 
week. 
Cells were permeabilized by zymolase treatment and then affixed to a 10 well 
microscope slide using poly-lysine.  15μl of poly-lysine was added to each well and 
allowed to air dry.  15μl of cell suspension was added and incubated for 5 minutes.  Cells 
were pipetted off and slide was allowed to air dry before being washed 3 times with 
1μg/ml PBS/BSA (Lippincott and Li, 1998b).   
Actin staining using A568 phalloidin (Invitrogen) was performed as described 
(Lippincott and Li 1998).  Mounting solution containing 1μg/ml DAPI was added and 
coverslip was sealed to slide. 
 
 
3.8. ACTIN STAINING OF cdc14-1 GAL1-SIC1ΔNT CELLS 
Strain KSY 504 with a temperature sensitive cdc14-1 allele and integrated GAL1-
SIC1ΔNT were used to selectively inhibit Cdc14p activity.  Cells were grown overnight 
in 5ml YPD at room temp (RT), after resuspension into YPGR (to express the Sic1 under 
the GAL1 promoter) nocodazole (5μg/ml) was added and cells incubated for 90 minutes 
to arrest cells in mitosis.  Cells were then placed at RT (control) and 37°C (experimental) 
for an additional 90 minutes to allow for inactivation of cdc14-1.  A sample was taken 
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before nocodazole was removed. After 2x dH20 washes a 10 minute and 20 minute time 
point was taken.  Cells were fixed by addition of formaldehyde to 5% and rotation for 1 
hour at room temperature.  Cells were then washed 2 times with sorbitol buffer to remove 
formaldehyde and stored at 4°C for up to a week. 
Cells were permeabilized by zymolase treatment and then affixed to a 10 well 
microscope slide using poly-lysine.  15μl of poly-lysine was added to each well and 
allowed to air dry.  15μl of cell suspension was added and incubated for 5 minutes.  Cells 
were pipetted off and slide was allowed to air dry before being washed 3 times with 
1μg/ml PBS/BSA (Lippincott and Li, 1998b).   
Actin staining using A568 phalloidin (Invitrogen) was performed as described 
(Lippincott and Li 1998).  Mounting solution containing 1μg/ml DAPI was added and 
coverslip was sealed to slide. 
 
3.9. FLUORESCENCE STAINING OF RESCUE CELLS 
Strain KSY 510 with a temperature sensitive cdc14-1 allele, the iqg1-4A plasmid 
(pDM9), a deletion of the wild type IQG1, and integrated GAL-SIC1ΔNT-myc was used 
to selectively inhibit Cdc14p activity, express the iqg1-4A mutant that prevents 
phosphorylation, and to bypass the MEN mutant arrest.  Cells were grown overnight in 
5ml YPD at room temperature (RT).  Cells were very slow growing, resulting in low cell 
density, which prevented acquisition of a nocodazole sample.  Cells were then 
resuspended in fresh YPD, nocodazole (5μg/ml) was added to arrest cells in metaphase, 
and incubated at RT for 90 minutes.  Then cells were resuspension into YPGR (to express 
the Sic1 under the GAL1 promoter) nocodazole (5μg/ml) and cells incubated at 37°C for 
additional 90 minutes to inactivate cdc14-1.  After 2x dH20 washes a 10 minute and 20 
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minute time point was taken.  Cells were fixed by addition of formaldehyde to 5% and 
rotation for 1 hour at room temperature.  Cells were then washed 2 times with sorbitol 
buffer to remove formaldehyde and stored at 4°C for up to a week. 
Cells were permeabilized by zymolase treatment and then affixed to a 10 well 
microscope slide using poly-lysine.  15μl of poly-lysine was added to each well and 
allowed to air dry.  15μl of cell suspension was added and incubated for 5 minutes.  Cells 
were pipetted off and slide was allowed to air dry before being washed 3 times with 
1μg/ml PBS/BSA (Lippincott and Li, 1998b).   
Cells were stained using primary antibody mouse anti-myc 9E10 (Covance) and 
FITC-conjugated secondary antibody (Jackson ImmunoResearch Laboratories, West 
Grove, PA) as described (Lippincott and Li 1998).  Actin staining using A568 phalloidin 
(Invitrogen) was also performed as described (Lippincott and Li 1998).  Mounting 
solution containing 1μg/ml DAPI was added and coverslip was sealed to slide. 
Images were captured using an Olympus IX51 inverted microscope at 1,000X 
total magnification using a UPLSAPO 100X NA 1.4 objective.  DA/FI/Tx-3X3M-a 
triple-band Sedat Filter set was used (Brightline).  Images were captured with a 
Hamamatsu ORCA285 CCD camera.  A prior motorized Z drive was used to capture 
image stacks of 20 Z-planes in 0.2μm steps.  Shutters, filters, and camera were controlled 
using SlideBook software (Intelligent Imaging Innovations, Denver, CO). 
 
 
3.10. YEAST PROTEIN EXTRACTS 
The protocol used is a modified version of Rigaut’s (Rigaut, Shevchenko et al. 
1999).  A 5ml YPGR culture was grown overnight at 30 °C.  The cells were then 
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resuspended in fresh YPGR media for 2 more hours at 30 °C then cells were pelleted and 
resuspended in 100μl U buffer (100mM Hepes, 1M KCL, 1M MgCl2, 100mM EGTA, 
dH20) +PIs (1000X) +PMSF (100x).  .3mg of acid washed glass beads were added to 
cells and chilled on ice for 10 minutes.  The cell suspension was vortexed 5 times (1 
minute on vortexer at max speed and 1 minute on ice).  The cell suspension was then 
centrifuged at 4°C on high speed for 5 min.  Sample was taken and concentration of 
protein was determined using a NanoDrop 1000 (Thermo Scientific).  100μl of 2X 
Lamelli Sample Buffer was added and tubes were boiled for 5 min then centrifuged again 
for 5 min on high speed, then frozen until use. 
 
 
3.11.  WESTERN BLOTTING 
Protein samples were separated on 7.5% SDS PAGE gels.  Transfer to 
nitrocellulose and block in 5% milk and TBST was performed before antibody staining.  
Mouse monoclonal anti-myc 9E10 (Covance) was used at 1:1000 concentration.  Donkey 
anti-mouse secondary antibody conjugated to HRP (Jackson Immuno research 
Laboratories, Inc.) was used at 1:5000 concentration.  The blot was then developed by 
using an ECL kit (SuperSignal West Pico Chemiluminescent Substrate, Thermo 
Scientific) and an image (Kodak is4000R image station with Carestream Molecular 







4.1. EFFECTS OF Iqg1 PHOSPHORYLATION MUTATIONS ON CYTOKINESIS 
In order to test the hypothesis that the phosphorylation state of Iqg1 affects the 
cell cycle regulation of actin ring formation we constructed two plasmids containing 
mutations of the four perfect consensus CDK sites (consensus sequence (S/TPxR/K, x is 
any amino acid (Li, Wang et al. 2008)).  These sites were identified by amino acid 
sequence analysis, and the four perfect CDK sites found in Iqg1 flank the CHD (Figure 
1.5).  Using site-directed PCR mutagenesis, each site was sequentially mutated to either 
alanine or glutamic acid.  Two alleles were generated, IQG1 with all four perfect sites 
mutated to alanine to prevent phosphorylation (iqg1-4A), and IQG1 with all sites mutated 
to glutamic acid to mimic phosphorylation (iqg1-4E).  Both alleles are under the 
endogenous IQG1 promoter and tagged at the C-terminus with 13 copies of the myc 
epitope. 
Defects in cytokinesis cause a distinct phenotype where cells fail to separate but 
continue the cell cycle re-budding over and over producing chains of cells until they lyse 
and die (Figure 9B).  To determine if mutation of the CDK phosphorylation sites affected 
cytokinesis, we examined the cell morphology of cells expressing the iqg1-4A and iqg1-
4E alleles.  Because it was uncertain if the mutant alleles would be viable, each plasmid 
was introduced into a yeast strain that contains the wild-type copy of IQG1 under the 
inducible GAL1 promoter.  This allows the cells to be grown while expressing the wild-
type copy of IQG1, and for the wild-type copy to be repressed in order to see the effects 
of the mutations expressed using IQG1 native promoter.  Cells were grown in YPD to 
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repress wild-type IQG1 for 5-7 hours before analysis.  Greater than 1000s cell per 
treatment group were analyzed using light microscopy for the chain phenotype (Figure 
4.1B).  The iqg1-4A more than doubles the occurrence of the chain phenotype (P = 0.018) 
(Figure 4.1) with a similar increase in iqg1-4E (P = 0.012).  However, defects in 
cytokinesis were high even when wild-type IQG1 was expressed in iqg1-4E.  In fact, the 
level of cytokinesis defects was as high in cells expressing wild type IQG1 and iqg1-4E 
as in cells expressing iqg1-4A alone.  The reason for this is unknown, but it is possible 
that iqg1-4E is acting as a dominant negative, or that since glutamic acid is only a mimic 
and not actually a phosphate it affects the protein in an unknown fashion. 
Since yeast cells have a cell wall it is possible this chain phenotype is caused by 
defects in either septation or cytokinesis.  To determine if the chain phenotype we 
observed in iqg1-4A was caused by cytokinesis defects or septation defects zymolyase 
treatment was performed as described (Lippincott and Li 1998).  Zymolyase breaks down 
the cell wall allowing for the degradation of the septum making it clear whether chains 
due to failure to separate the cell wall or the cell membrane.  Even after zymolyase 
treatment iqg1-4A cells had double the rate of chains compared to controls (Figure 4.1).  







Figure 4.1 Effect of Iqg1 Phosphorylation Mutants on Cytokinesis.  
A) Normal cell morphology.  B) Example of the chain phenotype.  C) Cells 
containing wild-type IQG1 under the GAL1 promoter and phosphorylation 
mutants expressed under the IQG1 promoter were grown in YPD (experimental) 
or YPGR (control).  For each replicate, 200 cells of each strain and treatment 








































Figure 4.2 Chain Phenotype in iqg1-4A cells Lacking Cell Wall. 
0.2 mg/ml of zymolyase 20T was added to cells after initial count and incubated for 15 
minutes to remove cell wall.  For each replicate, 200 cells of each strain and treatment 
were counted and scored as chains if they contained 3 or more connected cell bodies. 
 
 
4.2. EXPRESSION LEVELS OF Iqg1 
Because one explanation for the cytokinesis defects seen with the IQG1 mutant 
alleles could be due to too little stable protein produced, protein levels were examined.  
To accomplish this we used strains in which iqg1-myc, iqg1-4A-myc, or iqg1-4E-myc 
were the sole sources of Iqg1.  All were expressed under the endogenous IQG1 promoter.  
Protein extracts were prepared and a Western Blot was performed to determine protein 
levels.  Before samples were loaded the concentration was determined to ensure equal 
amounts of protein were loaded.  500μg of total protein, of each extract, was loaded into 
an SDS-page gel.  It is clear from the Western Blot below (Figure 4.3) that there are 

































Figure 4.3 Western Blot of Iqg1 Levels in Mutant and Control Cells. 
500μg of extract was loaded into each lane.   
 
4.3. MUTATIONS THAT PREVENT PHOSPHORYLATION OF THE Iqg1 CDK 
SITES CAUSE FORMATION OF THE ACTIN RING PRIOR TO ANAPHASE 
In the yeast Candida albicans, mutation of 15 Cdk1 consensus sites in Iqg1 to 
alanine resulted in premature assembly of the actomyosin ring and cytokinesis defects 
(Li, Wang et al. 2008).  It has also recently be reported that in budding yeast Cdc28 
phosphorylates Iqg1 (Zhang, Morgan et al. 2014).  To determine the effects of preventing 
Iqg1 phosphorylation on the regulation of actin ring formation, the timing of actin ring 
formation was examined in synchronous cell cultures.  Cells were arrested in G1 using 
mating factor.  After release from the arrest point a time course was performed with time 
points taken every 20 minutes up to 100 minutes.  The cells were fixed and stained using 
antibodies and phalloidin to stain for Iqg1 and F-actin respectively.  Images of ~5000 
cells (Figure 4.4) were taken and analyzed for the presence of actin and Iqg1 rings 
(Figure 4.5).   
In wild-type cells, Iqg1 localizes to the bud neck in anaphase, with actin 
following shortly thereafter (Lippincott and Li 1998, Lippincott, Shannon et al. 2001).  In 
the iqg1-4A mutant cells, formation of the actin ring occurred 20 minutes earlier in the 
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time course than in control cells.  Approximately 13% of cells had both an Iqg1 ring and 
actin ring 40 minutes after release from arrest, whereas control cells had less than 1% at 
this time point (p-value= 9.2x10-6) (Figure 4.5).  Figure 4.4B shows an iqg1-4A cell at 40 
minutes that has formed its Iqg1 and actin ring prior to anaphase, indicated by the single 
DNA mass.  Figure 4.4C shows a control cell at 60 minutes, clearly evident is both an 
Iqg1 ring and an actin ring as well as 2 DNA masses indicating that the cell is in 
anaphase or telophase.  At 60 minutes some iqg1-4A cells have yet to go through 
anaphase but have already assembled both Igq1 and actin rings (Figure 4.4D).  There was 
also a 10% higher occurrence of rings at the 60 minute time point (P = 0.011) (Figure 
4.5).  This data supports the hypothesis that phosphorylation of the 4 CDK sites in Iqg1 




Figure 4.4 Actin Rings Form Prior to Anaphase in iqg1-4A cells.  
Three color imaging of cells fixed during synchronous growth.  A) Control cells at 
40minutes after release from G1 arrest. B) iqg1-4A at 40minutes.  C) Control cells at 






Figure 4.5 Quantification of Iqg1 and Actin Ring Formation in Synchronized Cells. 
Cells were arrested in G1, released from arrest, and time points were taken every 20 
minutes.  Cell were then fixed and stained for Iqg1 and actin.  5 replicates were done with 




4.4. OVEREXPRESSION OF IQG1 DOES NOT AFFECT TIMING OF ACTIN 
RING FORMATION 
A possible explanation for the pre-anaphase assembly of the actin ring is the 
overexpression of iqg1-4A protein.  Figure 4.3 shows that mutant proteins are expressed 
at higher levels than controls.   To determine if overexpression of wild-type IQG1 causes 
early actin ring formation, yeast strains with wild-type IQG1 under the inducible GAL1 
promoter, were examined for actin rings in synchronous cell culture.  Cells were arrested 
in G1, released from arrest and samples taken and fixed every 15 minutes.  Cells were 






































started forming actin rings at the 60 minute mark indicating that overexpression of IQG1 
is not sufficient to cause early formation of the actin ring (Figure 4.6).  This is in contrast 
to the previously reported data that overexpression of IQG1 promoted early formation of 
the actin ring (Epp and Chant 1997). 
 
 
Figure 4.6 Effects of Overexpression of Iqg1 on Actin Ring Formation. 
Cells were arrested in G1 with a mating factor in either YPD (control) or YPGR (Iqg1 
overexpression), then released from arrest, fixed at fifteen minute intervals, and stained 
for actin (K. Shannon unpublished data) 
 
4.5. INHIBITING Cdc28 DOES NOT CAUSE ACTIN RING FORMATION 
The premature assembly of both the Iqg1 and actin rings in iqg1-4A 
phosphomutant cells might be duplicated by inhibition of the CDK that phosphorylates 
Iqg1.  Cdc28 drives the cell cycle and the cdc28-4 mutant allele of this kinase causes 
cells to arrest at two points in the cell cycle, G1 and late mitosis (Mendenhall and Hodge 
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1998).  To test this hypothesis we first needed to know if cells arrested at the mitotic 
arrest caused by cdc28-4 mutant allele produced actin rings.  The mutant cdc28-4 is a 
temperature sensitive allele that is inhibited at 37°C.  Cells were grown at 37°C for 3 
hours to inactivate Cdc28, then fixed and stained using A568 phalloidin (Invitrogen).  
More than 1000 large budded cells were analyzed, none of which had the actin ring 
structure.  It is possible that Iqg1 is not expressed until after the point in the cell cycle at 
which these cell arrest.  Therefore we wanted to determine if overexpressing Iqg1 was 
sufficient to cause formation of the actin ring in these cells.  A plasmid containing a copy 
of Iqg1 under the GAL1 promoter was inserted into cells with the mutant allele and the 
experiment was repeated.  Once again >1000 large budded cells were analyzed, none of 
them contained actin rings.   Contrary to our hypothesis overexpression of IQG1 is not 
sufficient to produce actin rings at the cdc28-4 arrest point. 
 
 
4.6. OVEREXPRESSION OF Cdc14 CAUSES EARLY FORMATION OF 
ACTOMYOSIN RING 
Cdc14 is the final protein in the MEN that is responsible for the degradation of 
mitotic cyclins and inactivation of Cdc28 resulting in exit from mitosis.  There is 
experimental evidence that MEN proteins play a role in cytokinesis other than 
inactivation of CDK (Jaspersen, Charles et al. 1998, Lippincott, Shannon et al. 2001, 
Meitinger, Petrova et al. 2010, Chin, Bennett et al. 2012, Devrekanli, Foltman et al. 2012, 
Meitinger, Palani et al. 2012, Oh, Chang et al. 2012).   
It has previously been reported that overexpression of Cdc14 improves the 
efficiency of cytokinesis when CDK is inactivated before anaphase (Sanchez-Diaz, Nkosi 
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et al. 2012).  In order to test the hypothesis that overexpression of Cdc14 causes early 
formation of the actin ring, we obtained the GAL1-CDC14 construct used by Sanchez-
Diaz et al.   Cells were arrested using the microtubule disruptor nocodazole, which 
activates the spindle assembly checkpoint arresting cells in prometaphase.  Cells were 
cultured in either in YPD (control) to inhibit the overexpression of Cdc14 or in YPGR 
(experimental) to induce the GAL1 promoter and drive overexpression of Cdc14.  Cells 
were incubated for 2.5 hours in nocodazole containing media and then fixed and stained.  
Over 1000 cells were analysis for actin rings using A568 phalloidin (Invitrogen).  Cells 
overexpressing Cdc14 formed twice as many actin rings compared to control cells while 
still arrested in mitosis (P = 0.008) (Figure 4.7).  Actin ring formation typically occurs in 
anaphase, these cells are arrested in prometaphase due to the nocodazole indicating 
Cdc14 plays a role in actin ring formation.  Control cells exhibited a higher percentage of 
actin rings than expected but this may be due to incomplete inhibition of the GAL1 








Figure 4.7 Overexpression of Cdc14 Causes Formation of Actin Rings During Mitotic 
Arrest. 
Cells containing CDC14 under the GAL1 promoter were used to selectively overexpress 
Cdc14.  Cells were arrested in M phase using nocodazole in media contain either glucose 
(control) or galactose (experimental) for 2.5 hours at 30 °C, then fixed for imaging.  
Actin rings were quantified.  In both replicates 100 cells per treatment type were 
analyzed for actin ring structures with a total analysis of 1200 cells.  A P-value for 0.008, 
was obtained using the student t-test. 
 
   
4.7. INHIBITION OF Cdc14 PREVENTS ACTIN RING FORMATION 
Cdc14 has a wide range of targets and inhibition of its activity causes arrest of the 
cell cycle in mitosis.  It has been shown that many MEN proteins including Tem1, Dbf2, 
and Mob1, are not required for actin ring formation (Lippincott, Shannon et al. 2001, 
Luca, Mody et al. 2001, Park, Cable et al. 2009, Oh, Chang et al. 2012).  Previous studies 
have also shown overexpression of Sic1 or can suppress a wide range of mutations in 
MEN proteins except for Cdc14 mutants (Fitzpatrick, Toyn et al. 1998, Jaspersen, 
Charles et al. 1998, Shou, Seol et al. 1999, Shou and Deshaies 2002).  Iqg1 is a potential 
Cdc14 substrate, and actin ring assembly occurs after inactivation of CDKs in anaphase.  
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at CDK sites.  To determine if actin ring formation requires Cdc14 function we utilized a 
temperature sensitive mutant allele of Cdc14, cdc14-1, and bypassed mitotic arrest using 
a 2 micron plasmid containing SIC1.  In budding yeast over expression of the Cdc28 
inhibitory protein Sic1 has been shown to bypass the requirement of MEN proteins for 
mitotic exit (Fitzpatrick, Toyn et al. 1998, Jaspersen, Charles et al. 1998).  We predicted 
that if Cdc14 activity is required for actin ring formation, ring formation will be blocked 
at the non-permissive temperature but not at room temperature.   
Cells were cultured overnight in YPD media.  Cells were resuspended in fresh 
YPGR (to overexpress Sic1) and synchronized in mitosis using nocodazole for 90 
minutes at room temperature.  Next they were incubated at RT (control) or 37°C 
(experimental), to inhibit cdc14-1 activity, for an additional 90 minutes.  Samples were 
taken during and after release from nocodazole arrest, fixed, and stained for actin. 
Mitotically arrested cells failed to form actin rings at the non-permissive 
temperature (P = 0.001) (Figure 4.8).  2% of these cells exhibited an actin ring but this is 
most likely due to incomplete nocodazole arrest, in fact most of the cells exhibiting an 
actin ring in nocodazole also had 2 DNA masses indicating that cells were past the arrest 
point.  The room temperature controls formed more actin rings than expected for cells 
arrested in mitosis, at ~18%.  This was due to the overexpression of Sic1 as previously 
reported (Sanchez-Diaz, Nkosi et al. 2012), where they discovered that overexpression of 
Sic1 promoted premature assembly of the actin ring.  This unexpected result bolsters our 
hypothesis as overexpression of Sic1, which inactivates Cdc28, is not sufficient to 
promote actin ring formation when Cdc14 is inhibited.    
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After release from mitotic arrest, actin ring formation in cdc14-1 cells remained 
significantly higher at room temperature compared to the non-permissive temperature 
(Figure 4.8).  This data shows that Cdc14 activity is required for actin ring formation in 
addition to its role in inactivating Cdc28’s kinase activity and destruction of mitotic 
cyclins. 
After release from the arrest a small increase in actin rings was observed in 
experimental cells.  It is possible this is caused by the short time these cells are at room 
temperature in the centrifuge in order to wash off the nocodazole.  The subsequent 
decrease at 20 minutes would support this hypothesis.   





Figure 4.8 Effect of Inhibiting Cdc14 Activity on Actin Ring Formation. 
Cells with a temperature sensitive cdc14-1 allele and an overexpressed Sic1 (2 micron 
plasmid) were diluted into YPD with addition of nocodazole for 90 minutes to arrest cells 
in mitosis.  Cells were then placed at RT or 37°C for 90 minutes, and fixed during and 


































4.8. iqg1-4A PHOSPHORYLATION MUTANT RESCUES cdc14-1 MUTANT’S 
ABILITY TO FORM ACTIN RINGS 
Cdc14 dephosphorylates many Cdc28 targets and is involved in regulation of 
mitotic exit, septation, and possibly cytokinesis.  Cdc14 has such a wide range of targets 
it’s possible the effects seen when overexpressing and inhibiting Cdc14 were caused by 
its activity on a range of different proteins.  When Cdc14 is inhibited, cells fail to produce 
an actin ring even in the presence of overexpressed Sic1, thus confirming the requirement 
of Cdc14’s activity on another protein.  Results from iqg1-4A experiments pointed to 
Iqg1 as the unknown protein. 
Both iqg1-4A and GAL1-CDC14 strains produced actin rings prior to anaphase 
revealing a possible link between Iqg1 and Cdc14.  Cdc14 has recently been shown to 
dephosphorylate Iqg1 at three of the four perfect consensus CDK sites flanking the CHD 
(Hall, unpublished data).  Together these results strongly implicated Iqg1 as the sole 
temporal regulatory target of actin ring formation and Cdc14 as its regulator. 
If Iqg1 is the exclusive target of Cdc14’s temporal control of actin ring formation 
than preventing phosphorylation of Iqg1 should be sufficient to promote actin ring 
formation even when Cdc14 is inhibited.   
To test this hypothesis two strains were constructed.  The first (KSY 504 the 
control) contains, a temperature sensitive allele, cdc14-1, that inhibits cdc14 at 37 
degrees, and integrated GAL-SIC1ΔNT-myc to bypasses MEN arrest.  The second (KSY 
510 the experimental) contains, both cdc14-1 mutant allele that inhibits cdc14 at 37 
degrees, and integrated GAL-SIC1ΔNT-myc to bypasses MEN arrest, as well as the 
plasmid pDM9 that expresses the iqg1-4A mutant that prevents phosphorylation of Iqg1, 
and deletion of wild type IQG1 (ΔIQG1).  Cells were synchronized in mitosis using 
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nocodazole for 90 minutes at room temperature.  Next they were resuspended in YPGR 
(to overexpress Sic1) with nocodazole and incubated at 37°C, to inhibit cdc14-1 activity, 
for an additional 90 minutes.  After release from nocodazole arrest a sample was taken at 
10 and 20 minutes, fixed, and stained using antibodies and phalloidin to stain for Iqg1 
and F-actin respectively.   
The iqg1-4A mutant does indeed rescue the cdc14-1 mutant allele’s ability to 
assemble an actin ring.  Similar to the previous experiment, KSY 504 control cells did 
not form a significant number of actin rings at either time point (~7%) (Figure 4.9).  
However, nearly half of all KSY 510 experimental cells produced actin rings (46%) 10 
minutes after release from nocodozale arrest (P = 0.0003).   
Cells expressing iqg1-4A at both 10 and 20 minute time points have actin and 
Iqg1 rings (Figure 4.10 C-D).  KSY 510 cells 10 minutes after release from metaphase 
arrest typically had single DNA mass indicating pre-anaphase cells (Figure 4.10 C), while 
20 minutes after release some cells have commenced anaphase, possibly telophase 
(Figure 4.10 D). 
These results demonstrate  that Iqg1 is the only Cdc14 target involved in temporal 
regulation of actin ring formation. 





Figure 4.9 Phosphomutant Rescues MEN Mutant. 
KSY strains 504 and 510 were grown overnight in YPD, then resuspended in fresh YPD 
with addition of nocodazole for 90 minutes to arrest cells in mitosis.  Cells were then 
placed resuspended in YPGR (to overexpress Sic1) with nocodazole and incubated at 
37°C for 90 minutes, and fixed after release from nocodazole at 10 and 20 minutes.  



























iqg1-4A Rescues cdc14-1 cells Ability to 







Figure 4.10 Phosphomutant Rescues MEN Mutant. 
Three color imaging of cells fixed cells after release from nocodazole.  A-B) KSY 504 
control cells at 10 and 20 minutes after release from metaphase.  C-D) KSY 510 







The goal of this study was to determine how actin ring assembly is temporally 
regulated.  This research focused on two proteins involved in cytokinesis, Iqg1 and 
Cdc14.  
Iqg1, which is essential for cytokinesis in budding yeast, contains 4 CDK sites 
flanking the CHD.  Iqg1’s CDK sites were mutated to prevent phosphorylation in order to 
determine how phosphorylation and dephosphorylation regulates actin ring formation.  
Cells containing iqg1-4A exhibited cytokinetic failure at double the rate of control cells 
indicating phosphorylation of Iqg1 plays some role in cytokinesis.  To explore this result 
further, immunofluorescence microscopy was utilized to determine what effect iqg1-4A 
had on timing of actin ring formation.  Cells expressing iqg1-4A assemble both Iqg1 and 
actin rings early, before the onset of anaphase, indicating phosphorylation of Iqg1 
negatively regulates actin ring formation.  These results led us to study Cdc14’s role in 
actin ring formation. 
The MEN protein Cdc14 is a phosphatase known to dephosphorylate Cdc28 
targets and lead to the degradation of mitotic cyclins and inhibition of Cdc28 resulting in 
exit from mitosis.  To determine what effects Cdc14 had on actin ring formation we first 
overexpressed it using the inducible GAL1 promoter.  Overexpression of Cdc14 caused 
assembly of the actin ring during mitotic arrest (~42%), indicating Cdc14 plays a role in 
the regulation of actin ring formation. 
Next we studied how inhibition of Cdc14 would affect actin ring formation.  We 
used a temperature sensitive cdc14-1 mutant allele to inhibit protein activity.  However, 
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Cdc14 mutants, like most components of the MEN, arrest in mitosis.  To bypass this 
arrest we overexpressed Sic1, an inhibitor of Cdc28 and well known for its ability to slip 
past MEN mutant arrest.  Inhibition of Cdc14 in cells overexpressing Sic1 prevented 
actin ring formation.  The controls formed more actin rings than expected for cells 
arrested in metaphase of mitosis (18%).  This was due to the overexpression of Sic1 as 
previously reported (Sanchez-Diaz, Nkosi et al. 2012).  This result reinforces our 
hypothesis, as normally overexpression of Sic1, which inactivates Cdc28, is enough to 
promote actin ring formation in mitotically arrested cells.  However, it is not sufficient to 
promote actin ring formation when Cdc14 is inhibited, demonstrating Cdc14 is required 
for actin ring formation.    
Overexpression of Cdc14 is sufficient to promote actin ring formation, while 
inhibition of Cdc14 prevents actin ring formation.  This result suggests that other 
components of the MEN are not required for actin ring formation other than their role in 
releasing Cdc14 from the nucleolus.  Other MEN mutants are not defective in actin ring 
formation when in the presence of increases in cytoplasmic Cdc14.  Overexpression of 
Sic1 causes a transient release of Cdc14 from the nucleolus to the cytoplasm (Chin, 
Bennett et al. 2012), the mechanism by which this occurs is unknown.  The release is 
most likely transient because Dbf2 phosphorylation of Cdc14’s Nuclear Localization 
Signal (NLS) if required for sustained release of Cdc14 from the nucleolus.  Our data 
demonstrate that actin ring formation requires the dephosphorylation of the Iqg1 protein. 
Our results prove that Cdc14 has an additional function in the temporal regulation 
of actomyosin ring formation in addition to its role in inactivation of Cdc28’s kinase 
activity and destruction of mitotic cyclins.   
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The iqg1-4A mutant that prevents phosphorylation exhibited a similar phenotype 
to cells overexpressing Cdc14, strongly implicating Iqg1 as the sole temporal regulatory 
target of actin ring formation and Cdc14 as its regulator.  The iqg1-4A mutant can rescue 
the cdc14-1 mutant’s ability to assemble an actin ring and in fact produces more actin 
rings than overexpressing Cdc14 does.  In these cells Cdc14 is functionally off while the 
Iqg1 phosphomutant iqg1-4A is more than sufficient to promote actin ring formation 
without Cdc14 activity, which proves that Iqg1 is the only Cdc14 target involved in 
temporal regulation of ring formation. 
It’s curious that early formation of the actin ring cause defects in cytokinesis.  It’s 
possible that the phosphorylation mutants have some defect in ring contraction causing 
the cytokinesis defects seen.  To test this hypothesis live cell imaging could be done on 
the phosphorylation mutants with the addition of MYO1-GFP to track ring contraction 
and TUB1-mCherry to indicate cell cycle progression.  Defects could also be due to 
defective contraction of the ring before septin hourglass splitting or primary septum 
formation, which may disrupt or block ring contraction.  Live cell imaging utilizing a 
septin probe or CHS2-GFP would help to test this hypothesis.   
This study raises the question of which mechanism of Cdc14 release from the 
nucleolus promotes actin ring formation.  Small amounts of Cdc14 are released by the 
Fourteen Early Anaphase Release network (FEAR) and it is possible that this is enough 
to promote actin ring formation.  However, ring formation may require a more extensive 
and sustained release of Cdc14 in which case it would require the Mitotic Exit Network 
and its role in fully releasing Cdc14.  To determine which mechanism of Cdc14 release is 
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responsible for Cdc14’s role in regulating actin ring formation we are looking at mutants 
of the FEAR network and their effects on actin ring formation.   
The Cdc14 released by the FEAR network does not become cytosolic but is 
instead dispersed through the nucleoplasm.  While MEN releases Cdc14 into the 
cytoplasm and prevents its relocalization to the nucleolus by phosphorylating Cdc14’s 
nuclear localization signal.  To determine which network is responsible for Cdc14s 
activities in actin ring formation utilization of CDC14-ECFP and IqgCHD-GFP with live 
cell imaging should prove which network it is in one simple experiment.  IqgCHD-GFP 
is an actin probe that only binds actin that is part of the actomyosin ring.  CDC14-ECFP 
on the other hand both marks the nucleolus in nocodazole arrested cells (as Cdc14 is 
localized there during early mitosis) and marks Cdc14’s position.  Once actin rings form 
localization of Cdc14 would indicate which network is responsible.  If the Cdc14 is still 
in the nucleus then is the FEAR, and Cdc14 is in the cytoplasm then it’s the MEN.  
Further evidence could be obtained using the cdc14-NES mutant allele that fails to export 
to the cytoplasm normally but still triggers destruction of mitotic cyclins.  Arrest cells in 
nocodazole and stain for actin.  If actin ring formation occurs it’s the FEAR if actin ring 
formation is prevented it’s the MEN.  If still not clear which network is responsible use 
cells with a deletion of CDC55, which can cause premature release of Cdc14 by the 
FEAR pathway (Wang and Ng 2006, Yellman and Burke 2006).  Or utilize cells with a 
deletion of BUB2, which triggers the MEN pathway in metaphase (Wang, Hu et al. 2000, 
Wang and Ng 2006) and look for actin rings in nocodazole arrested cells.  
Curiously in the yeast S. pombe, Cdc14 mutants exit mitosis normally but are 
altered in septation and cytokinesis.  S. pombe inactivate their CDK (Cdc2) by down 
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regulating Cdc25 phosphatase.  While S. pombe don’t require Cdc14 to inactivate CDKs, 
it’s clearly still required for efficient cytokinesis and septation.  One explanation for this 
is Cdc14 activity is still required to dephosphorylate Chs2 to release it from the ER 
allowing efficient septation (Chin, Bennett et al. 2012), and is probably needed to 
dephosphorylate S. pombe’s IQGAP family member, Rng2 for efficient ring formation 
and cytokinesis.  
Another question raised is whether phosphorylation of these CDK sites alters the 
CHD’s ability to bind to F-actin.  Since the CDK sites flank the CHD it is possible they 
regulate Iqg1’s ability to bind F-actin.  To test whether the phosphorylation mutants alter 
actin binding an actin probe with a fragment of Iqg1 containing the CHD tagged with 
GFP is under construction.   It could also change the way Iqg1 folds effecting Iqg1’s 
protein:protein interactions.  The phosphorylation mutants could affect Iqg1’s 
interactions with formin proteins Bni1 and Bnr1.  The most likely culprit is Myo1.  Myo1 
is targeted to the bud neck initially by Bni5 and interactions with septin proteins (Lee, 
Song et al. 2002).  However later in mitosis Myo1 localization depends on its interactions 
with Mlc1 and Iqg1 (Bi, Maddox et al. 1998, Lippincott and Li 1998, Shannon and Li 
1999, Lee, Song et al. 2002, Fang, Luo et al. 2010).  To determine is Myo1 localization is 
affected by the iqg1-4A cells with MYO1-GFP and iqg1-4A could be used with a 
nocodazole arrest then live cell imaging.  Data before release from arrest would verify 
Myo1 localization to the bud neck prior to its dependency on Iqg1, and after arrest Iqg1 
dependent localization could be monitored.  
Further analysis of iqg1-4A and its effects on cytokinesis and septation should be 
coupled with investigation of the chs2-4A mutant allele.  While investigation of the 
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FEAR and MEN regulated release of Cdc14 should utilize Cdc14’s location as an 
indicator of which pathway is in control as well as deletion mutants that trigger each 
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